Authors' recommendations: Health Problem: Surgical site infections (SSIs) contribute significant morbidity, mortality, and increased costs despite institutions often employing multiple interventions designed to reduce or eliminate SSI incidence. Technology Description: Triclosan-coated sutures were developed to prevent microbial adherence and colonization and have the same strength, durability, and ease of use as similar sutures without triclosan coating. Controversy: The use of triclosan in consumer products is not without controversy. The popularity of antibacterial products in the consumer market has been aided by the public perception that these products prevent infection. The widespread use of triclosan in consumer products and its detection in breast milk, urine, and serum have raised concerns regarding its potential association with resistance to antibiotics. Key Questions: Does use of triclosan-coated sutures reduce the incidence of SSI compared with conventional sutures? Are triclosan-coated sutures safe compared with conventional sutures? Have definitive patient-selection criteria for triclosan-coated sutures been established?

Project Status: Completed

Year Published: 2017

URL for published report: The report may be purchased from: http://www.hayesinc.com/hayes/crd/?crd=13609

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: United States

Organisation Name: HAYES, Inc.

Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218

Contact Name: saleinfo@hayesinc.com

Contact Email: saleinfo@hayesinc.com

Copyright: Winifred S. Hayes, Inc